Arteriosclerosis, Thrombosis, Vascular Biology
Science NewsView All Science News
03/25/2019 | CIRCULATION RESEARCH Featured articles for march 2019
03/25/2019 | New featured articles from JAHA for March 19, 2019
03/17/2019 | The purpose of this guideline is to review and consolidate existing recommendations into a single guidance document focused on the primar...
03/14/2019 | Hypertension is the most prevalent chronic disease in the world but determining the precise cause of elevated blood pressure may not be p...
Vascular Discovery: From Genes to Medicine 2019
May 14–16, 2019
Boston, Massachusetts
Related Councils
Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB)
The Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) contributes to the mission and objectives of the American Heart Association (AHA) through efforts in the fields of arteriosclerosis, thrombosis and vascular biology. The council advances and coordinates research, addresses prevention, improves methods for diagnosis and treatment, and works actively with other organizations concerned with these issues. The council disseminates reliable information related to these fields through its annual conference, many awards and lectures, and the AHA's journal, Arteriosclerosis, Thrombosis, and Vascular Biology.
Mary Sorci-Thomas, PhD, FAHA
Chair, Council on Arteriosclerosis, Thrombosis and Vascular Biology
Council on Peripheral Vascular Disease (PVD)
The Council on Peripheral Vascular Disease (PVD) seeks to integrate the academic and clinical missions of all interdisciplinary vascular health professionals in order to expand professional and public vascular education; to advance the basic science and clinical research and evidence based practice; and to thereby improve clinical outcomes of individuals with PVD.
Aruna D. Pradhan, MD, MPH
Chair, Council on Peripheral Vascular Disease
Daily Polls & Quizzes
How have aspirin recommendations changed with the new CVD Primary Prevention Guideline?
Podcast series on the link between cardiovascular disease (CVD) and type 2 diabetes (T2D) with cutting-edge topics such as up-to-date standards of care, guidelines and their implications for T2D and CVD, and approaches to shared decision making — among other topics. Listen today and improve your patient’s outcomes!
